1 Market Overview of Fibrin Degradation Product (FnDP) Assays 1.1 Fibrin Degradation Product (FnDP) Assays Market Overview 1.1.1 Fibrin Degradation Product (FnDP) Assays Product Scope 1.1.2 Fibrin Degradation Product (FnDP) Assays Market Status and Outlook 1.2 Global Fibrin Degradation Product (FnDP) Assays Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Fibrin Degradation Product (FnDP) Assays Market Size by Region (2016-2027) 1.4 Global Fibrin Degradation Product (FnDP) Assays Historic Market Size by Region (2016-2021) 1.5 Global Fibrin Degradation Product (FnDP) Assays Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) 1.6.1 North America Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) 1.6.2 Europe Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) 1.6.3 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) 1.6.4 Latin America Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) 1.6.5 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) 2 Fibrin Degradation Product (FnDP) Assays Market Overview by Type 2.1 Global Fibrin Degradation Product (FnDP) Assays Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Fibrin Degradation Product (FnDP) Assays Historic Market Size by Type (2016-2021) 2.3 Global Fibrin Degradation Product (FnDP) Assays Forecasted Market Size by Type (2022-2027) 2.4 Plasma 2.5 Serum 3 Fibrin Degradation Product (FnDP) Assays Market Overview by Application 3.1 Global Fibrin Degradation Product (FnDP) Assays Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Fibrin Degradation Product (FnDP) Assays Historic Market Size by Application (2016-2021) 3.3 Global Fibrin Degradation Product (FnDP) Assays Forecasted Market Size by Application (2022-2027) 3.4 Hospital 3.5 Specialty Clinics 3.6 Diagnostic Laboratory 3.7 Others 4 Fibrin Degradation Product (FnDP) Assays Competition Analysis by Players 4.1 Global Fibrin Degradation Product (FnDP) Assays Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fibrin Degradation Product (FnDP) Assays as of 2020) 4.3 Date of Key Players Enter into Fibrin Degradation Product (FnDP) Assays Market 4.4 Global Top Players Fibrin Degradation Product (FnDP) Assays Headquarters and Area Served 4.5 Key Players Fibrin Degradation Product (FnDP) Assays Product Solution and Service 4.6 Competitive Status 4.6.1 Fibrin Degradation Product (FnDP) Assays Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Sekisui Diagnostics (Sekisui Chemical) 5.1.1 Sekisui Diagnostics (Sekisui Chemical) Profile 5.1.2 Sekisui Diagnostics (Sekisui Chemical) Main Business 5.1.3 Sekisui Diagnostics (Sekisui Chemical) Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions 5.1.4 Sekisui Diagnostics (Sekisui Chemical) Fibrin Degradation Product (FnDP) Assays Revenue (US$ Million) & (2016-2021) 5.1.5 Sekisui Diagnostics (Sekisui Chemical) Recent Developments 5.2 Randox Laboratories 5.2.1 Randox Laboratories Profile 5.2.2 Randox Laboratories Main Business 5.2.3 Randox Laboratories Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions 5.2.4 Randox Laboratories Fibrin Degradation Product (FnDP) Assays Revenue (US$ Million) & (2016-2021) 5.2.5 Randox Laboratories Recent Developments 5.3 Beckman Coulter Inc. (Danaher Corporation) 5.5.1 Beckman Coulter Inc. (Danaher Corporation) Profile 5.3.2 Beckman Coulter Inc. (Danaher Corporation) Main Business 5.3.3 Beckman Coulter Inc. (Danaher Corporation) Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions 5.3.4 Beckman Coulter Inc. (Danaher Corporation) Fibrin Degradation Product (FnDP) Assays Revenue (US$ Million) & (2016-2021) 5.3.5 Kamiya Biomedical Company Recent Developments 5.4 Kamiya Biomedical Company 5.4.1 Kamiya Biomedical Company Profile 5.4.2 Kamiya Biomedical Company Main Business 5.4.3 Kamiya Biomedical Company Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions 5.4.4 Kamiya Biomedical Company Fibrin Degradation Product (FnDP) Assays Revenue (US$ Million) & (2016-2021) 5.4.5 Kamiya Biomedical Company Recent Developments 5.5 ADALTIS S.r.l. 5.5.1 ADALTIS S.r.l. Profile 5.5.2 ADALTIS S.r.l. Main Business 5.5.3 ADALTIS S.r.l. Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions 5.5.4 ADALTIS S.r.l. Fibrin Degradation Product (FnDP) Assays Revenue (US$ Million) & (2016-2021) 5.5.5 ADALTIS S.r.l. Recent Developments 5.6 SDIX, LLC 5.6.1 SDIX, LLC Profile 5.6.2 SDIX, LLC Main Business 5.6.3 SDIX, LLC Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions 5.6.4 SDIX, LLC Fibrin Degradation Product (FnDP) Assays Revenue (US$ Million) & (2016-2021) 5.6.5 SDIX, LLC Recent Developments 5.7 Lab Mark A.s. 5.7.1 Lab Mark A.s. Profile 5.7.2 Lab Mark A.s. Main Business 5.7.3 Lab Mark A.s. Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions 5.7.4 Lab Mark A.s. Fibrin Degradation Product (FnDP) Assays Revenue (US$ Million) & (2016-2021) 5.7.5 Lab Mark A.s. Recent Developments 5.8 Abbott Laboratories 5.8.1 Abbott Laboratories Profile 5.8.2 Abbott Laboratories Main Business 5.8.3 Abbott Laboratories Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions 5.8.4 Abbott Laboratories Fibrin Degradation Product (FnDP) Assays Revenue (US$ Million) & (2016-2021) 5.8.5 Abbott Laboratories Recent Developments 5.9 IBL International (Tecan Group Ltd.) 5.9.1 IBL International (Tecan Group Ltd.) Profile 5.9.2 IBL International (Tecan Group Ltd.) Main Business 5.9.3 IBL International (Tecan Group Ltd.) Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions 5.9.4 IBL International (Tecan Group Ltd.) Fibrin Degradation Product (FnDP) Assays Revenue (US$ Million) & (2016-2021) 5.9.5 IBL International (Tecan Group Ltd.) Recent Developments 5.10 Analytik Jena AG 5.10.1 Analytik Jena AG Profile 5.10.2 Analytik Jena AG Main Business 5.10.3 Analytik Jena AG Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions 5.10.4 Analytik Jena AG Fibrin Degradation Product (FnDP) Assays Revenue (US$ Million) & (2016-2021) 5.10.5 Analytik Jena AG Recent Developments 6 North America 6.1 North America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Fibrin Degradation Product (FnDP) Assays Market Dynamics 11.1 Fibrin Degradation Product (FnDP) Assays Industry Trends 11.2 Fibrin Degradation Product (FnDP) Assays Market Drivers 11.3 Fibrin Degradation Product (FnDP) Assays Market Challenges 11.4 Fibrin Degradation Product (FnDP) Assays Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Fibrin Degradation Product (FnDP) Assays Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Fibrin Degradation Product (FnDP) Assays Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Fibrin Degradation Product (FnDP) Assays Market Size Share by Region (2016-2021) Table 4. Global Fibrin Degradation Product (FnDP) Assays Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Fibrin Degradation Product (FnDP) Assays Forecasted Market Size Share by Region (2022-2027) Table 6. Global Fibrin Degradation Product (FnDP) Assays Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share by Type (2016-2021) Table 9. Global Fibrin Degradation Product (FnDP) Assays Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share by Type (2022-2027) Table 11. Global Fibrin Degradation Product (FnDP) Assays Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share by Application (2016-2021) Table 14. Global Fibrin Degradation Product (FnDP) Assays Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share by Application (2022-2027) Table 16. Global Fibrin Degradation Product (FnDP) Assays Revenue (US$ Million) by Players (2016-2021) Table 17. Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fibrin Degradation Product (FnDP) Assays as of 2020) Table 19. Date of Key Manufacturers Enter into Fibrin Degradation Product (FnDP) Assays Market Table 20. Global Fibrin Degradation Product (FnDP) Assays Top Players Headquarters and Area Served Table 21. Fibrin Degradation Product (FnDP) Assays Product Solution and Service Table 22. Global Fibrin Degradation Product (FnDP) Assays Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Sekisui Diagnostics (Sekisui Chemical) Basic Information List Table 25. Sekisui Diagnostics (Sekisui Chemical) Description and Business Overview Table 26. Sekisui Diagnostics (Sekisui Chemical) Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions Table 27. Revenue (US$ Million) in Fibrin Degradation Product (FnDP) Assays Business of Sekisui Diagnostics (Sekisui Chemical) (2016-2021) Table 28. Sekisui Diagnostics (Sekisui Chemical) Recent Developments Table 29. Randox Laboratories Basic Information List Table 30. Randox Laboratories Description and Business Overview Table 31. Randox Laboratories Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions Table 32. Revenue (US$ Million) in Fibrin Degradation Product (FnDP) Assays Business of Randox Laboratories (2016-2021) Table 33. Randox Laboratories Recent Developments Table 34. Beckman Coulter Inc. (Danaher Corporation) Basic Information List Table 35. Beckman Coulter Inc. (Danaher Corporation) Description and Business Overview Table 36. Beckman Coulter Inc. (Danaher Corporation) Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions Table 37. Revenue (US$ Million) in Fibrin Degradation Product (FnDP) Assays Business of Beckman Coulter Inc. (Danaher Corporation) (2016-2021) Table 38. Beckman Coulter Inc. (Danaher Corporation) Recent Developments Table 39. Kamiya Biomedical Company Basic Information List Table 40. Kamiya Biomedical Company Description and Business Overview Table 41. Kamiya Biomedical Company Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions Table 42. Revenue (US$ Million) in Fibrin Degradation Product (FnDP) Assays Business of Kamiya Biomedical Company (2016-2021) Table 43. Kamiya Biomedical Company Recent Developments Table 44. ADALTIS S.r.l. Basic Information List Table 45. ADALTIS S.r.l. Description and Business Overview Table 46. ADALTIS S.r.l. Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions Table 47. Revenue (US$ Million) in Fibrin Degradation Product (FnDP) Assays Business of ADALTIS S.r.l. (2016-2021) Table 48. ADALTIS S.r.l. Recent Developments Table 49. SDIX, LLC Basic Information List Table 50. SDIX, LLC Description and Business Overview Table 51. SDIX, LLC Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions Table 52. Revenue (US$ Million) in Fibrin Degradation Product (FnDP) Assays Business of SDIX, LLC (2016-2021) Table 53. SDIX, LLC Recent Developments Table 54. Lab Mark A.s. Basic Information List Table 55. Lab Mark A.s. Description and Business Overview Table 56. Lab Mark A.s. Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions Table 57. Revenue (US$ Million) in Fibrin Degradation Product (FnDP) Assays Business of Lab Mark A.s. (2016-2021) Table 58. Lab Mark A.s. Recent Developments Table 59. Abbott Laboratories Basic Information List Table 60. Abbott Laboratories Description and Business Overview Table 61. Abbott Laboratories Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions Table 62. Revenue (US$ Million) in Fibrin Degradation Product (FnDP) Assays Business of Abbott Laboratories (2016-2021) Table 63. Abbott Laboratories Recent Developments Table 64. IBL International (Tecan Group Ltd.) Basic Information List Table 65. IBL International (Tecan Group Ltd.) Description and Business Overview Table 66. IBL International (Tecan Group Ltd.) Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions Table 67. Revenue (US$ Million) in Fibrin Degradation Product (FnDP) Assays Business of IBL International (Tecan Group Ltd.) (2016-2021) Table 68. IBL International (Tecan Group Ltd.) Recent Developments Table 69. Analytik Jena AG Basic Information List Table 70. Analytik Jena AG Description and Business Overview Table 71. Analytik Jena AG Fibrin Degradation Product (FnDP) Assays Products, Services and Solutions Table 72. Revenue (US$ Million) in Fibrin Degradation Product (FnDP) Assays Business of Analytik Jena AG (2016-2021) Table 73. Analytik Jena AG Recent Developments Table 74. North America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2021) & (US$ Million) Table 75. North America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2022-2027) & (US$ Million) Table 76. Europe Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2021) & (US$ Million) Table 77. Europe Fibrin Degradation Product (FnDP) Assays Market Size by Country (2022-2027) & (US$ Million) Table 78. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Region (2016-2021) & (US$ Million) Table 79. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Region (2022-2027) & (US$ Million) Table 80. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Share by Region (2016-2021) Table 81. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Share by Region (2022-2027) Table 82. Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2021) & (US$ Million) Table 83. Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2022-2027) & (US$ Million) Table 84. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Players (2016-2021) & (US$ Million) Table 85. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Country (2022-2027) & (US$ Million) Table 86. Fibrin Degradation Product (FnDP) Assays Market Trends Table 87. Fibrin Degradation Product (FnDP) Assays Market Drivers Table 88. Fibrin Degradation Product (FnDP) Assays Market Challenges Table 89. Fibrin Degradation Product (FnDP) Assays Market Restraints Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Global Fibrin Degradation Product (FnDP) Assays Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Fibrin Degradation Product (FnDP) Assays Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Fibrin Degradation Product (FnDP) Assays Market Share by Regions: 2021 VS 2027 Figure 4. Global Fibrin Degradation Product (FnDP) Assays Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Fibrin Degradation Product (FnDP) Assays Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Fibrin Degradation Product (FnDP) Assays Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Fibrin Degradation Product (FnDP) Assays Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Fibrin Degradation Product (FnDP) Assays Market Size Share by Type in 2021 & 2027 Figure 11. Plasma Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Serum Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Global Fibrin Degradation Product (FnDP) Assays Market Size Share by Application in 2021 & 2027 Figure 14. Hospital Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Specialty Clinics Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Diagnostic Laboratory Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Fibrin Degradation Product (FnDP) Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 19. Global Top 5 and Top 10 Players Fibrin Degradation Product (FnDP) Assays Market Share in 2020 Figure 20. North America Fibrin Degradation Product (FnDP) Assays Market Share by Country (2016-2027) Figure 21. United States Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 22. Canada Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 23. Germany Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 24. France Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 25. U.K. Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 26. Italy Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 27. Russia Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 28. Nordic Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 29. Rest of Europe Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 30. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Share by Region (2016-2027) Figure 31. China Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 32. Japan Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 33. South Korea Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 34. Southeast Asia Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 35. India Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 36. Australia Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 37. Rest of Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 38. Latin America Fibrin Degradation Product (FnDP) Assays Market Share by Country (2016-2027) Figure 39. Mexico Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 40. Brazil Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Latin America Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 42. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Share by Country (2016-2027) Figure 43. Turkey Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 44. Saudi Arabia Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 45. UAE Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 46. Rest of Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027) & (US$ Million) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation

Sekisui Diagnostics (Sekisui Chemical) Randox Laboratories Beckman Coulter Inc. (Danaher Corporation) Kamiya Biomedical Company ADALTIS S.r.l. SDIX, LLC Lab Mark A.s. Abbott Laboratories IBL International (Tecan Group Ltd.) Analytik Jena AG